Deferasirox
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Deferasirox |
| DrugBank ID | DB01609 |
| KG Predictions | 98 |
| DL Predictions (≥0.7) | 190 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 98 knowledge graph predictions and 190 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| beta-thalassemia and related diseases | KG |
| hemoglobinopathy | KG |
| beta-thalassemia HBB/LCRB | KG |
| dominant beta-thalassemia | KG |
| beta-thalassemia intermedia | KG |
| hereditary persistence of fetal hemoglobin | KG |
| beta thalassemia | KG |
| beta-thalassemia and related diseases | KG |
| hemoglobinopathy | KG |
| beta-thalassemia HBB/LCRB | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB01609
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.